Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
BMC Gastroenterology|June 29, 2023
Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessationYandi Xie, Minghui Li, Xiaojuan Ou, et al.
Annals of Translational Medicine|November 4, 2021
Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in ChinaRunqin Li, Xiao Lin, Jing-Yue Wang, et al.
BMC Gastroenterology|January 4, 2026
HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patientsYandi Xie, Xiaojing Zhang, Xiaozhou Yang, et al.
Scientific Reports|September 7, 2017
M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytesLi Bai, Xin Liu, Qingfen Zheng, et al.
Journal of Viral Hepatitis|March 11, 2022
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analoguesYang Wang, Hao Liao, Zhongping Deng, et al.
Journal of Molecular Cell Biology|November 28, 2013
Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-β is critical for immune homeostasis following acute liver injuryLing Lu, Min Feng, Jia Gu, et al.
Cellular and Molecular Life Sciences : CMLS|October 26, 2024
Stromal softness confines pancreatic cancer growth through lysosomal-cathepsin mediated YAP1 degradationTianci Zhang, Jingjing Chen, Huan Yang, et al.
Hepatology International|November 17, 2025
Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferonJianxia Dong, Shan Ren, Pengxuan Wu, et al.
International Journal of Medical Sciences|June 13, 2022
Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patientsYang Wang, Yanna Liu, Hao Liao, et al.
Journal of Clinical and Translational Hepatology|September 12, 2025
Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE StudyHonglian Gui, Yingqiu Shen, Lin Tan, et al.
Pageof 12